Literature DB >> 27818099

How Dextran Sulfate Affects C1-inhibitor Activity: A Model for Polysaccharide Potentiation.

Madelon Dijk1, Jolande Holkers2, Patrick Voskamp1, Bruno M Giannetti2, Willem-Jan Waterreus1, Harrie A van Veen3, Navraj S Pannu4.   

Abstract

C1-inhibitor is a key inhibitor of the complement and contact activation systems, and mutations in the protein can cause hereditary angioedema. Through an unknown mechanism, polysaccharides can increase C1-inhibitor activity against some of its target proteases. Here we present the crystal structures of the serine protease inhibitor (serpin) domain of active C1-inhibitor by itself and in complex with dextran sulfate. Unlike previously described interactions of serpins with polysaccharides, the structures and isothermal titration calorimetry experiments together reveal that dextran sulfate binds to C1-inhibitor's F1 helix with low affinity and does not invoke an allosteric change. Furthermore, one dextran sulfate molecule can bind multiple C1-inhibitor molecules. We propose that in a C1-inhibitor/protease/polysaccharide ternary complex, negatively charged polysaccharides link C1-inhibitor's positively charged F1 helix to positively charged autolysis loops of proteases. The proposed mechanism elegantly explains previous experiments showing that polysaccharide potentiation is increased against proteases with a greater positive charge in their autolysis loop. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C1-inhibitor; complement system; contact system; polysaccharide potentiation; serine protease inhibitor

Mesh:

Substances:

Year:  2016        PMID: 27818099     DOI: 10.1016/j.str.2016.09.013

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  2 in total

Review 1.  A bite so sweet: the glycobiology interface of tick-host-pathogen interactions.

Authors:  Pavlina Vechtova; Jarmila Sterbova; Jan Sterba; Marie Vancova; Ryan O M Rego; Martin Selinger; Martin Strnad; Maryna Golovchenko; Nataliia Rudenko; Libor Grubhoffer
Journal:  Parasit Vectors       Date:  2018-11-14       Impact factor: 3.876

2.  Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19.

Authors:  Xiyuan Bai; Ashley M Buckle; Eszter K Vladar; Edward N Janoff; Reeti Khare; Diane Ordway; David Beckham; Lorelenn B Fornis; Abraham Majluf-Cruz; Randolph V Fugit; Brian M Freed; Soohyun Kim; Robert A Sandhaus; Edward D Chan
Journal:  Sci Rep       Date:  2022-03-25       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.